Estrogen acts in a brain region to reduce sleep in female rats
Experiments in adult female rats with ovaries removed identified a site where estradiol, a form of estrogen, altered sleep and wakefulness.
Our read
Mechanisms- Studied:
- Experiments in adult female ovariectomized Sprague–Dawley rats
- What changed:
- Estradiol-treated female rats spent about 50 more minutes awake during the dark phase than at baseline
- The catch:
- Infusions could spread outside the median preoptic nucleus, so other regions could drive the effects
- In the record:
- One of 714 papers on estradiol on record: 170 with results in people, 243 in animals.
Editor of record: Boris Djordjevic · AgingResearch.News
Adult female Sprague–Dawley rats whose ovaries had been removed received estradiol, a form of estrogen, in experiments tracking brain electrical activity and muscle activity. The rats received 5 micrograms, then 10 micrograms 24 hours later, after an oil-only baseline injection. Estradiol increased wakefulness and reduced both major sleep stages, mainly during the dark phase. The 12-hour dark phase after the higher dose included about 50 more minutes awake than at baseline.
Infusing estradiol into the median preoptic nucleus, a brain region, reproduced the sleep–wake effects. Blocking estrogen receptors—proteins that respond to estrogen—in that region reduced estradiol’s effects on wakefulness and non-rapid eye movement sleep, but not rapid eye movement sleep. Both estrogen receptor types, alpha and beta, were required for the sleep–wake effects.
Why it matters
Sleep disruptions during hormonal transitions, including menopause, raise questions about how ovarian hormones affect sleep. The authors identify this brain region as a potential target for sleep disorders related to hormonal changes.
Caveats
The authors note that brain infusions may have spread beyond the intended region, potentially producing effects elsewhere.
The paper
University of Maryland, Baltimore
Sleep, Jan 12, 2026, Open access
Comments
Be the first to comment.